Author: Mukuntha Subburayan

Chirag Shah, PharmD Head, Strategic Publications & Medical Education Medical Affairs, Neurocrine Biosciences, Inc.   “In clinical trials for valbenazine, approved for treating tardive dyskinesia (TD)—a persistent and...

In July 2020, experts participated in individual semi-structured qualitative interviews about how tardive Dyskinesia (TD) is diagnosed and treated in real-world settings. A virtual roundtable follow-up was conducted in November...

Researchers presented the findings  of cognitive behavioral therapy (CBT) benefits on anxiety, depression, and quality of life in patients with mild cognitive impairment (MCI) and dementia “Today, no reviews have analyzed...

By: Chirag Shah; Shereta Wiley; Sylvie Stacy; Leslie Lundt In a poster session, researchers sought to understand the evolving continuing medical education (CME) needs of psychiatrists managing patients with tardive dyskinesia...

As an involuntary movement disorder resulting from exposure to dopamine antagonists, tardive dyskinesia (TD) classically manifests as involuntary oro-bucco-lingual and facial dyskinesia, as well as limb, trunk, and respiratory...

There is growing number of treatment-refractory patients in psychiatric practice. Although evidence-based treatments may be effective in most patients, there is a significant number of psychiatric patients, who may not have an...

Data from the real-world RE-KINECT study were analyzed to better understand the impact of tardive dyskinesia (TD) on wellbeing and health state in patients who are aware of their TD. Over 200 adults with over 3 months of...

A year since COVID-19 was declared a worldwide emergency, experts warn that a subsequent mental health pandemic is imminent, due to the lasting adverse impacts of stress, anxiety and isolation. This year’s Annual Meeting offers...

Friday, April 30, 2021 11:00 a.m. – 5:30 p.m. ET Pre-Conference Expo Virtual Exhibit Gallery Product Theater Showcases Saturday, May 1, 2021 10:00 a.m. – 11:00 a.m. ET Opening Session (Plenary), Featuring Keynote Speaker Isabel...

Schedule Friday, April 30, 2021 Noon – 1:00 p.m. ET  Supported by Axsome Therapeutics Inc.  [Product Theater 1] New Pathways in Depression: Potential to Improve Clinical Outcomes  Roger S. McIntyre MD, FRCP Professor of...

APA is pleased to announce that Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases will deliver the 2021 William C. Menninger Memorial Convocation Lecture on May 2. At NIAID, Fauci...